BioRestorative Therapies, Inc. (NASDAQ: BRTX) reported Q2 EPS of ($0.50), $0.05 better than the analyst estimate of ($0.55).

For earnings history and earnings-related data on BioRestorative Therapies, Inc. (BRTX) click here.